Key results: 12 mg dose: Average weight loss of 24.2 percent of body weight 8 mg dose: Average weight loss of 22.8 percent 4 mg dose: Average weight loss of 17.0 percent Over 90 percent of participants at 8 or 12 mg lost at least 10 percent of body weight Over 75 percent at 12 mg lost at least 20 percent Crucially, the weight loss curve had not yet plateaued at 48 weeks, suggesting longer treatment may produce even greater results
How long before I might see improvements in my pain
Ensure you stay well-hydrated, as both medications can occasionally cause nausea or loose stools
Spieles-Engemann AL, Behbehani MM, Collier TJ, et al
Semaglutide, which is also available under the brand names Ozempic and Rybelsus, is a GLP-1 receptor agonist that has been shown to help people with type 2 diabetes lose weight, lower glucose levels, and protect against diabetes-related heart complications
Huge shoutout to Zoey for being so welcoming and Imelda for doing such a great job with the IV